This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

BSD Reports Growing Interest In Hyperthermia Systems At American Society For Radiation Oncology (ASTRO) Meeting

BSD Medical Corporation (NASDAQ:BSDM) (Company or BSD) (, a leading provider of medical systems that utilize targeted heat therapy to treat cancer, today announced growing interest in hyperthermia at the 2012 international conference of the American Society for Radiation Oncology (ASTRO). ASTRO is the largest radiation oncology society in the world, and the annual conference is the premier worldwide scientific meeting in radiation oncology. The theme of the 2012 meeting was “Advancing Patient Care Through Innovation.”

BSD offers technologically innovative products that provide targeted heat therapy for the treatment of cancer. Hyperthermia has been shown to be the most potent radiosensitizing agent known to date and has demonstrated the ability to increase the effectiveness of radiation and many chemotherapeutic agents for certain tumors.

“Exhibiting at ASTRO allowed BSD to showcase the Company’s hyperthermia technology to interested physicians and distributors throughout the world,” stated Harold R. Wolcott, President of BSD Medical. “We were pleased with the increased level of interest in hyperthermia shown by both the U.S. and the international medical community and distributors.”


ASTRO is the largest radiation oncology organization of its kind and has more than 10,000 members. Their members include radiation oncologists, radiation oncology nurses, medical physicists, radiation therapists, dosimetrists and biologists, the medical professionals that are part of the medical teams that treat more than 1 million cancer patients each year. ASTRO is committed to excellence in patient care through a team-based approach to treatment.

About the BSD Hyperthermia Systems

The BSD-500 Hyperthermia System (BSD-500) is used to deliver therapeutic, targeted heat therapy (hyperthermia) using either non-invasive (external) or interstitial (internal) applicators. The BSD-500 has received U.S. Food and Drug Administration (FDA) pre-market approval (PMA), which is the standard FDA approval required to market Class III medical devices in the United States, for the use of hyperthermia alone or in conjunction with radiation therapy for the treatment of certain tumors. Clinical studies have shown that hyperthermia delivered using the BSD-500 can significantly increase the effectiveness of radiation therapy without a significant increase in toxicity for certain tumors.

1 of 3

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free


Chart of I:DJI
DOW 17,812.19 +19.51 0.11%
S&P 500 2,089.14 +2.55 0.12%
NASDAQ 5,102.8080 +0.33 0.01%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs